Sunday, May 28, 2023
  • Janam TV Malayalam
  • About Us
  • Contact Us
  • Privacy Policy
  • Terms of Services
Janam TV English
  • ‌
  • News
    • Kerala
    • India
    • Gulf
    • World
  • Business
  • Defence
  • Tech
  • Science
  • Health
  • Podcast
  • ‌
    • Travel
    • Entertainment
    • Lifestyle
    • Sports
    • Guest Column
    • Auto
No Result
View All Result
  • ‌
  • News
    • Kerala
    • India
    • Gulf
    • World
  • Business
  • Defence
  • Tech
  • Science
  • Health
  • Podcast
  • ‌
    • Travel
    • Entertainment
    • Lifestyle
    • Sports
    • Guest Column
    • Auto
No Result
View All Result
Janam TV English
No Result
View All Result
  • News
  • Business
  • Defence
  • Health
Home News India

Zydus Cadila seeks emergency use nod for its for 12+ age COVID-19 vaccine

by Janam Web Desk
Jul 1, 2021, 09:26 pm IST
in India, Health

Ahmedabad based drugmaker Zydus Cadila has applied for Emergency Use Authorisation (EUA) to the country’s regulator DCGI for ZyCoV-D- its COVID-19 vaccine.

The vaccine that is meant for use among all age groups, and can be used for those aged 12 years and above has concluded its third phase trials of the vaccine. The drugmaker has claimed that it has carried out the largest clinical trials for its Plasmid DNA vaccine against coronavirus in India, in more than 50 centres.

“Around 1000 subjects were enrolled in this age group and the vaccine was found to be safe and very well tolerated. Tolerability profile was similar to that seen in the adult population and primary efficacy of 66.6% was been attained for symptomatic RT-PCR positive cases in the interim analysis. Whereas no moderate case of COVID-19 disease was observed in the vaccine arm post administration of the third dose suggesting 100% efficacy for moderate disease. No severe cases or deaths due to COVID-19 occurred in the vaccine arm after administration of the second dose of the vaccine,” Zydus Cadila said in a statement.

The company added that it plans to produce up to 120 million doses of the jab annually, once it gets the regulator’s nod.

According to the company, ZyCoV-D had already exhibited a robust immunogenicity, tolerability and safety profile in the adaptive Phase me/II clinical trials carried out earlier. Both the Phase I/II and Phase III clinical trials have been monitored by an independent Data Safety Monitoring Board.

This was also the first time that any COVID-19 vaccine has been tested in adolescent population in the 12-18 years age bracket in the country.

Zydus’ vaccine named as ZyCoV-D if approved, would be the fifth vaccine authorized for use in India, after Serum Institute of India’s Covishield licensed by Astra Zeneca , Bharat Biotech’s Covaxin, and Sputnik V developed by Russia’s Gamaleya Institute and Moderna which applied for EUA yesterday.

According the company, ZyCoV-D showed safety and efficacy in a late-stage trial with more than 28,000 volunteers across the country, including about 1,000 subjects in the 12-18-year age group.

The study was reportedly carried out during the peak of second wave of COVID-19 in India and confirms the vaccine’s efficacy against the new mutant strains, especially the Delta variant which is wreaking havoc in Europe and many other countries.

Tags: emergency useZydus CadilaZyCoV-DMAINFEATUREDCOVID 19 vaccine
Share1TweetSendShare

Comments

Refrain from posting comments that are obscene, defamatory or inflammatory, and do not indulge in personal attacks, name calling or inciting hatred against any community. Keep the conversation civil.

Related News

BJP National President J P Nadda will inaugurate party offices in various districts in Kerala today
News

New Parliament building is a significant milestone in the journey of independent India: BJP National Chief JP Nadda

NIA raids house of SDPI leader and former secretary of Popular Front
India

Terror conspiracy case: NIA raids 13 locations in Madhya Pradesh

‘Is Kerala govt taking more loans to pay honorarium to KV Thomas?’ asks Minister of State V Muraleedharan
News

‘Is Kerala govt taking more loans to pay honorarium to KV Thomas?’ asks Minister of State V Muraleedharan

Latest News

Manchester United qualifies for Champions League

Manchester United qualifies for Champions League

Need to expand more research activities in Himalayan region: Union Minister Kiren Rijiju

Need to expand more research activities in Himalayan region: Union Minister Kiren Rijiju

Arikomban wreaks havoc in residential areas, destroys vehicles; ‘Operation Arikomban’ is on, Section 144 enforced in Cumbum

Arikomban wreaks havoc in residential areas, destroys vehicles; ‘Operation Arikomban’ is on, Section 144 enforced in Cumbum

Midfielder Sahal Abdul Samad to leave Kerala Blasters?

Midfielder Sahal Abdul Samad to leave Kerala Blasters?

Stalker sets girl on fire; 22 year old girl dies in Thrissur

Fire breaks out at KMSCL’s warehouse in Alappuzha; third incident in a row

PM feels proud of our Innovators as India climbs to the 40th rank in  the Global Innovation Index of WIPO

‘Vision 2047’; Prime Minister Modi will preside the 8th NITI Aayog Governing Council meeting in Delhi

‘Why Sengol was marked as Nehru’s walking stick in museum? Congress must apologise to TN people’, says BJP State Chief Annamalai

‘Why Sengol was marked as Nehru’s walking stick in museum? Congress must apologise to TN people’, says BJP State Chief Annamalai

Gill’s exhilarating sixes shatters the sixth IPL trophy expectations of Mumbai Indians, Gujarat Titans enters final

Gill’s exhilarating sixes shatters the sixth IPL trophy expectations of Mumbai Indians, Gujarat Titans enters final

  • Janam TV Malayalam
  • About Us
  • Contact Us
  • Privacy Policy
  • Terms of Services

© Janam Multimedia Limited

No Result
View All Result
  • ‌
  • News
    • Kerala
    • India
    • Gulf
    • World
  • Business
  • Defence
  • Tech
  • Science
  • Health
  • Podcast
  • ‌
    • Travel
    • Entertainment
    • Lifestyle
    • Sports
    • Guest Column
    • Auto

© Janam Multimedia Limited